Ignite Creation Date:
2025-12-25 @ 5:02 AM
Ignite Modification Date:
2026-02-01 @ 7:57 AM
Study NCT ID:
NCT02562118
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-25
First Post:
2015-09-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer
Sponsor:
National University Hospital, Singapore
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06
Completion Date Type:
ESTIMATED
First Submit Date:
2015-09-08
First Submit QC Date:
None
Study First Post Date:
2015-09-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-25
Last Update Post Date Type:
ESTIMATED